Engineering stem cells and tissues for better health
01 September 2008The Cambridge Stem Cell Initiative enters its second phase with the launch of the Laboratory for Regenerative Medicine.
Advancing the surface technology of materials
01 September 2008Research at the Gordon Laboratory is opening up an important new area for the surface engineering of materials.
Collagen mechanics: learning from nature
01 September 2008Because of their unique structure, biological tissues exhibit physical and mechanical properties that are unlike anything in the world of engineering.
‘Super’ superalloys: hotter, stronger, for even longer
01 September 2008Only a single class of engineering materials can withstand the extreme conditions deep within a jet aeroplane engine – the nickel-base superalloys.
Lean machines: environmentally friendly engines
01 September 2008An industrial-grade aerospace gas turbine combustion simulator – the first of its kind in the UK and one of only a dozen worldwide – is...
Widening participation in higher education
01 September 2008New research could help improve the learning experience of students from backgrounds where there is little tradition of higher education.
Re-interpreting Greece and Rome at The Fitzwilliam Museum
01 September 2008Recent funding will enable collaboration between classicists and museum curators, and shape a major re-display of Greek and Roman art and archaeology.
Weaving a web of world history
01 September 2008For five researchers embarking on the project ‘Civilizations in Contact’, finding the links between each of their specialist fields will provide unique insight into pre-modern...
Sharing and researching best practice in human resources
01 September 2008Judge Business School have launched a major new forum devoted to excellence in global human resource management – the Centre for International Human Resource Management...
"Academic Incubator" to develop new medicines of value
01 September 2008GlaxoSmithKline (GSK) has signed its first agreement with the University to optimise the early clinical development of new GSK medicines for obesity and addictive disorders.